Naive Like CAR T Product Cells Track Durable Lymphoma Benefit
A peer reviewed multicenter analysis of axicabtagene ciloleucel products from 580 patients with non-Hodgkin lymphoma links a higher pre-infusion CCR7+CD45RA+ naive like or stem memory like T cell fraction to more durable clinical benefit….
